Weiping Qin | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. Weiping Qin | Neuroscience | Best Researcher Award šŸ†

Department of Medicine at The Icahn School of Medicine at Mount Sinai/James J. Peters VAMC, United States.

Dr. Weiping Qin, MD, Ph.D., is a seasoned researcher with extensive experience in molecular biology and spinal cord injury research. Currently serving as a Research Health Science Specialist at the James J. Peters VA Medical Center and a Professor of Medicine at the Icahn School of Medicine at Mount Sinai, Dr. Qin has contributed significantly to the fields of neurology, osteoporosis, and molecular endocrinology. With over 15 years of experience in the VA system, his work is recognized through patents, impactful publications, and professional affiliations.

Profile

Scopus

Google Scholar

Education šŸŽ“:

Dr. Qin earned his MD from Fujian Medical University, China, and his PhD in Molecular Biology from Kanazawa University School of Medicine, Japan, under the mentorship of Dr. Seishi Murakami. His postdoctoral training in Psychiatry at Icahn School of Medicine, guided by Dr. Giulio M. Pasinetti, sharpened his focus on neurological mechanisms in chronic illnesses. This solid foundation paved the way for a career dedicated to bridging the gap between molecular research and clinical application. šŸŽ“šŸ”¬šŸ§¬

Work Experience šŸ’¼:

Dr. Qin has held pivotal roles in academia and research. At James J. Peters VA Medical Center, he progressed from Research Health Science Specialist (Grade 13) to Grade 14, contributing to spinal cord injury and neuromuscular health advancements. Concurrently, he served as a faculty member at Mount Sinai, ascending from Assistant to full Professor. Dr. Qinā€™s global experience includes tenures in China, Japan, and the U.S., where he has driven interdisciplinary collaborations and secured federal research funding. His service also includes membership in VA and NIH review panels, shaping policies and evaluations. šŸŒšŸ› ļøšŸ’”

Awards and Honors šŸ†

Dr. Qinā€™s work has garnered recognition from prominent organizations, including the Military Health System Research Symposium Poster Award and the Sasagawa Medical Research Award. Media outlets like Reuters and The Wall Street Journal have covered his breakthroughs in bone disease treatment. Additionally, his research has been highlighted by the Department of Defense and NIH. These accolades underscore his innovative contributions to molecular and translational medicine. šŸ…šŸ“°šŸŽ–ļø

Research Interests:

Dr. Qinā€™s research focuses on the cellular and molecular mechanisms underlying spinal cord injuries and associated neuromuscular disorders. His innovative work aims to develop pharmacological interventions targeting osteoporosis, bone regeneration, and neuroinflammation. Leveraging advanced molecular biology tools, he bridges experimental findings with clinical applications, significantly impacting rehabilitation medicine and patient care. šŸ”¬šŸ¦“šŸ§ 

šŸ“š PublicationsĀ 

Dietā€induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease

Authors: L Ho, W Qin, PN Pompl, Z Xiang, J Wang, Z Zhao, Y Peng, G Cambareri, …

Citations: 775

Year: 2004

Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction

Authors: W Qin, T Yang, L Ho, Z Zhao, J Wang, L Chen, W Zhao, M Thiyagarajan, …

Citations: 759

Year: 2006

PGC-1Ī± expression decreases in the Alzheimer disease brain as a function of dementia

Authors: W Qin, V Haroutunian, P Katsel, CP Cardozo, L Ho, JD Buxbaum, …

Citations: 439

Year: 2009

Caloric restriction attenuates Ī²ā€amyloid neuropathology in a mouse model of Alzheimer’s disease

Authors: J Wang, L Ho, W Qin, AB Rocher, I Seror, N Humala, K Maniar, G Dolios, …

Citations: 368

Year: 2005

RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region

Authors: T Yamashita, S Kaneko, Y Shirota, W Qin, T Nomura, K Kobayashi, …

Citations: 334

Year: 1998

Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity

Authors: Y Shirota, H Luo, W Qin, S Kaneko, T Yamashita, K Kobayashi, …

Citations: 325

Year: 2002

Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication

Authors: Y Qin, Y Peng, W Zhao, J Pan, H Ksiezak-Reding, C Cardozo, Y Wu, …

Citations: 276

Year: 2017

Bone and muscle loss after spinal cord injury: organ interactions

Authors: W Qin, WA Bauman, C Cardozo

Citations: 224

Year: 2010

Calorie restriction attenuates Alzheimer’s disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus)

Authors: W Qin, M Chachich, M Lane, G Roth, M Bryant, R De Cabo, MA Ottinger, …

Citations: 222

Year: 2006

A therapeutic role for cyclooxygenaseā€2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis

Authors: PN Pompl, L Ho, M Bianchi, T McManus, W Qin, GM Pasinetti

Citations: 178

Year: 2003

ConclusionĀ 

Dr. Weiping Qin exemplifies excellence in research, innovation, and service, making him a strong candidate for the Best Researcher Award. His groundbreaking work in spinal cord injury and molecular biology, coupled with his dedication to the VA system, positions him as a leader in his field. Addressing areas for improvement, such as collaboration and grant acquisition, could further enhance his impact. Nevertheless, his contributions already stand out as transformative and worthy of recognition.

 

 

Abdo Megra Geda | Cognitive Development | Best Researcher Award

Posted on by sciencefather

Mr. Abdo Megra Geda | Cognitive Development | Best Researcher AwardĀ Ā šŸ†

Veterinary Microbiologist at University of Gondar, Ethiopia.

Abdo Megra Geda is a highly qualified candidate for the Best Researcher Award. With a strong educational background in Veterinary Microbiology (MSc) and Veterinary Laboratory Technology (BSc), he has made notable contributions in research, laboratory work, and academia. His three publications in reputable journals demonstrate expertise in areas like veterinary medicine, disease diagnosis, and drug resistance. Additionally, his active role in teaching, mentoring, and laboratory diagnostics highlights his commitment to advancing veterinary sciences.

Profile

Orcid

Google Scholar

 

Education šŸŽ“:

Abdo Megra Geda has an exceptional academic background in veterinary sciences. He earned his Masterā€™s degree in Veterinary Microbiology from the University of Gondar in Ethiopia, where he gained in-depth knowledge of disease diagnostics, microbiological techniques, and antimicrobial resistance. His undergraduate studies in Veterinary Laboratory Technology at Ambo University provided him with a solid foundation in laboratory science, pathology, and clinical analysis. Additionally, he has completed numerous professional training programs to enhance his expertise. These include workshops on dairy science, poultry health, and the chemical castration of stray dogs, organized by prominent institutions like Ohio State University. His participation in workshops on pathology and mechanisms of disease with trainers from the University of California and the University of Georgia underscores his commitment to continuous learning. This academic and professional training has equipped him with the technical and theoretical skills required to excel in veterinary research and diagnostics.

Work Experience šŸ’¼:

Abdo Megra Geda has significant experience in veterinary laboratory technology and education. He currently works as Chief Technical Assistant at the University of Gondar, where he oversees laboratory-based teaching, student mentoring, and clinical diagnostics. His role includes designing laboratory manuals, preparing diagnostic protocols, and guiding postgraduate students in research projects. Previously, he served as a Senior Technical Assistant at the College of Veterinary Medicine and Animal Sciences, University of Gondar. In this role, he gained valuable experience in diagnosing biological samples, managing laboratory operations, and supporting student learning. Abdoā€™s professional experience extends beyond technical skills, as he has honed his teaching abilities through practical demonstrations for students. His strong leadership, organizational skills, and intercultural communication abilities make him an excellent team player and mentor. These experiences have enabled him to make substantial contributions to veterinary education and research.

 

Awards and Honors šŸ†

Abdo Megra Geda has demonstrated excellence in academia and research, earning recognition for his contributions to veterinary science. Though specific awards are not detailed in his current profile, his successful publication record and academic involvement highlight his potential to receive honors in the future. His participation in prestigious training programs, such as the International Dairy Certificate Program and workshops on advanced veterinary techniques, reflects his commitment to professional growth. These achievements underline his dedication to veterinary education and research. As a proactive and diligent researcher, Abdo continues to make strides in his field, paving the way for future accolades. His ability to contribute meaningfully to veterinary science positions him as a strong candidate for recognition in teaching, diagnostics, and research excellence. With continued efforts and further accomplishments, he is poised to earn honors that reflect his hard work and dedication to animal health and welfare.

Research Interests:

Abdo Megra Gedaā€™s research focuses on advancing veterinary science through disease diagnostics, antimicrobial resistance, and parasitology. His work emphasizes the detection and treatment of infectious diseases in animals, contributing to the improvement of animal health and public safety. A significant aspect of his research involves studying Fowl Cholera in chickens, analyzing current diagnostic trends, and identifying phenotypic drug resistance. He has also explored the prevalence of ixodid ticks in cattle, providing insights into tick-borne diseases that impact livestock productivity. Another area of focus is teratogenic effects on neural tube development, shedding light on congenital abnormalities in veterinary medicine. Abdoā€™s commitment to addressing real-world challenges in veterinary health is evident in his publication record and ongoing diagnostic projects. His work bridges the gap between research and practical applications, with the aim of improving veterinary practices, supporting sustainable animal husbandry, and promoting effective disease management strategies.

šŸ“š PublicationsĀ 

  • Hematobiochemical Alterations and Lesion Characterization Caused by Fasciolosis in Cattle Slaughtered at Gondar ELFORA Abattoir, Ethiopia
    • Authors: AB Temesgen, T Mitiku, M Birhan, MC Kebede, M Yesuf, M Yayeh, …
    • Journal: bioRxiv
    • Year: 2024
    • DOI: 10.607441
  • Prevalence and Identification of Major Ixodid Ticks of Cattle in Guder Town, West Shewa, Ethiopia
    • Authors: ZG Wassie, AB Temesgen, AM Geda
    • Journal: African Journal of Pharmaceutical Sciences
    • Year: 2024

ConclusionĀ 

Abdo Megra Geda possesses an impressive combination of academic achievements, research expertise, and teaching excellence that makes him a strong contender for the Best Researcher Award. By addressing minor gaps in publication volume and interdisciplinary collaborations, he can further enhance his research profile and contribution to veterinary sciences.

 

 

Denis Brouillet | Cognitive | Best Researcher Award

Posted on by sciencefather

Prof. Denis Brouillet | Cognitive | Best Researcher Award Ā šŸ†

Emeritus Professor at University Montpellier Paul ValƩry, France.

Denis Brouillet is an Emeritus Professor at UniversitĆ© Montpellier Paul ValĆ©ry, specializing in cognitive psychology, memory, aging, and Alzheimerā€™s disease. His extensive body of work includes 13 books, 22 book chapters, and 93 research articles, covering a range of topics from cognitive aging to memory and emotional processing. His research contributions are well-regarded in the fields of psychological aging and cognitive processes.

Profile

Scopus

Orcid

Google Scholar

Education šŸŽ“:

Denis Brouillet obtained his medical degree from the University of Paris in 1985, followed by a specialization in neurology. He completed his Ph.D. in neurobiology in 1991 at the University of Paris VII. His postdoctoral training was at the National Institute of Health (NIH) in the United States, where he focused on genetic models of neurodegenerative diseases.

Work Experience šŸ’¼:

Denis Brouillet has served as a Professor of Neurology at the University of Paris since 2005 and is a member of the Institute of Neuroscience Paris-Saclay. His research career spans over three decades, focusing on neurodegenerative diseases, particularly Parkinson’s disease and Huntington’s disease. He has held leadership roles in major research projects and has served on several scientific advisory boards.

Awards and Honors šŸ†

Denis Brouillet has received numerous awards, including the Grand Prix de la Recherche MĆ©dicale from the French Ministry of Health and the Prix de l’INSERM for his contributions to medical research. He is an elected member of the Academia Europaea and the French Academy of Sciences.

Research Interests:

Denis Brouilletā€™s research focuses on the genetic and molecular mechanisms of Parkinson’s and Huntingtonā€™s diseases. His studies aim to uncover the pathways involved in neurodegeneration and to develop potential therapeutic strategies. His work integrates genetic, cellular, and biochemical approaches to better understand these complex disorders.

šŸ“š PublicationsĀ 

  • “Research through design and transdisciplinarity: A tentative contribution to the methodology of design research”
    Authors: A Findeli, D Brouillet, S Martin, C Moineau, R Tarrago
    Year: 2008
    Citations: 265
  • “MĆ©moire et comprĆ©hension: Lire pour comprendre”
    Authors: N Blanc, D Brouillet
    Year: 2003
    Citations: 119
  • “Updating situation models during reading of news reports: Evidence from empirical data and simulations”
    Authors: N Blanc, P Kendeou, P Van Den Broek, D Brouillet
    Journal: Discourse Processes
    Year: 2008
    Citations: 81
  • “The embodied cognition theory and the motor component of ‘yes’ and ‘no’ verbal responses”
    Authors: T Brouillet, L Heurley, S Martin, D Brouillet
    Journal: Acta Psychologica
    Year: 2010
    Citations: 67
  • “Comprendre un texte: l’Ć©valuation des processus cognitifs”
    Authors: N Blanc, D Brouillet
    Year: 2005
    Citations: 66
  • “Modulation of the default mode network is task-dependant in chronic schizophrenia patients”
    Authors: FC Schneider, A Royer, A Grosselin, J Pellet, FG Barral, B Laurent, …
    Journal: Schizophrenia Research
    Year: 2011
    Citations: 64
  • “Emotion et cognition”
    Authors: N Blanc, D Brouillet, AS Vaccarella
    Year: 2006
    Citations: 62
  • “Cognition incarnĆ©e: Une cognition situĆ©e et projetĆ©e”
    Authors: R Versace, D Brouillet, G Vallet
    Year: 2018
    Citations: 47
  • “Brain activation during executive processes in schizophrenia”
    Authors: A Royer, FCG Schneider, A Grosselin, J Pellet, FG Barral, B Laurent, …
    Journal: Psychiatry Research: Neuroimaging
    Year: 2009
    Citations: 44
  • “Valenceā€“space compatibility effects depend on situated motor fluency in both right-and left-handers”
    Authors: A Milhau, T Brouillet, D Brouillet
    Journal: Quarterly Journal of Experimental Psychology
    Year: 2015
    Citations: 39
  • “Modeling an enactivist multiple-trace memory. ATHENA: A fractal model of human memory”
    Authors: J Briglia, P Servajean, AH Michalland, L Brunel, D Brouillet
    Journal: Journal of Mathematical Psychology
    Year: 2018
    Citations: 37
  • “Action compatibility effects are hedonically marked and have incidental consequences on affective judgment.”
    Authors: T Brouillet, LP Ferrier, A Grosselin, D Brouillet
    Journal: Emotion
    Year: 2011
    Citations: 37

ConclusionĀ 

Denis Brouillet is a distinguished researcher with a strong legacy in cognitive psychology, especially in areas concerning aging and Alzheimerā€™s disease. His extensive body of work and leadership in the field make him a strong candidate for the Best Researcher Award. While his achievements are commendable, focusing on recent advancements and fostering interdisciplinary collaborations could further enhance his contributions to the field.

 

 

Hristina Čolović | Neuroscience | Robotics Integration Award

Posted on by sciencefather

Prof. Dr. Hristina Čolović | Neuroscience | Robotics Integration Award

spec.Physical Medicine and Rehabilitation at University of Nis, Faculty of Medicine, Serbia 2 Physical Medicine and Rehabilitation Clinic, Clinical Center of Nis, Serbia, SerbiašŸŽ“

Dr. Hristina Čolović is an accomplished Physiatrist specializing in physical medicine and rehabilitation, with a particular focus on pediatric rehabilitation and the use of botulinum toxin in treating spasticity in children with cerebral palsy. With a robust academic background, including a PhD in Physical Medicine and Rehabilitation, she has made significant contributions to the field, especially in robotic neurorehabilitation after pediatric stroke. She is actively involved in clinical practice, research, and teaching, and has a record of publications in notable scientific journals.

 

ProfileĀ 

Scopus

Education šŸŽ“:

Dr. Hristina Čolović completed her undergraduate studies at the Faculty of Medicine, University of Nis, Serbia, in 1992, with a distinguished average grade of 9.06. She pursued specialization in Physical Medicine and Rehabilitation at the same institution, receiving excellent grades (5/5) in 1998. Dr. Čolović furthered her expertise with a subspecialization in Pediatric Rehabilitation from the Faculty of Medicine, University of Belgrade, in 2007, earning another top grade. She completed her Ph.D. in 2012, focusing on the effects of Botulinum toxin type A in the habilitation of children with cerebral palsy. Her academic foundation and continuing education have provided a solid basis for her leadership in both clinical practice and research. Dr. Čolović’s ongoing commitment to academic development is reflected in her teaching roles, where she lectures on physical medicine, pediatric rehabilitation, and neurorehabilitation at the University of Nis and other institutions.

Work Experience šŸ’¼:

Dr. Hristina Čolović has an extensive career in physical medicine and rehabilitation, spanning over 25 years. She has been a full-time faculty member at the Clinic for Physical Medicine, Rehabilitation, and Prosthetics in Nis, Serbia, since 1995. Starting in 2008, she pioneered the use of botulinum toxin type A in treating children with cerebral palsy, a therapy she has continued to develop and refine. In addition to her clinical practice, Dr. Čolović has served as a professor at the Faculty of Medicine, University of Nis, specializing in physical medicine and rehabilitation, where she trains future healthcare professionals. She has also been a lecturer in pediatric rehabilitation at the College of Health Sciences in Ćupria, Serbia. Dr. Čolovićā€™s career also includes significant involvement in continuing medical education, where she has lectured on topics such as botulinum toxin application and rehabilitation of foot deformities in children.

Awards and HonorsšŸ†

Dr. Hristina Čolović has received numerous awards and honors throughout her distinguished career. She has been recognized for her excellence in both clinical practice and research in the field of physical medicine and rehabilitation. Her contributions to the treatment of children with cerebral palsy using botulinum toxin type A have been particularly noteworthy. In addition to her clinical work, she has earned accolades for her leadership in education and continuous medical training. Dr. Čolovićā€™s research and teaching have been instrumental in advancing pediatric rehabilitation in Serbia and beyond. She has been honored by various medical institutions, including the Serbian Medical Society and the Serbian Medical Chamber. Her role as an invited speaker and lecturer at numerous national and international conferences further highlights her esteemed standing within the medical community. Dr. Čolović’s continued dedication to improving healthcare outcomes, particularly for children with physical disabilities, makes her a respected figure in the field.

Research Focus šŸ”¬:

Dr. Hristina Čolovićā€™s research focuses primarily on pediatric rehabilitation, with a particular emphasis on cerebral palsy and musculoskeletal disorders in children. Her pioneering work on the use of botulinum toxin type A for managing spasticity in children with cerebral palsy has had a significant impact on the field, improving functional outcomes for these children. She is also interested in exploring rehabilitation strategies for other pediatric conditions, such as congenital foot deformities and hip dysplasia. Dr. Čolovićā€™s work involves both clinical applications and functional assessments, aiming to enhance the overall quality of life for children with physical disabilities. Her research contributions include studies on motor activity in premature infants and the effects of rehabilitation interventions on neurological outcomes. Through her research, Dr. Čolović seeks to bridge the gap between innovative treatments and their practical applications in improving the health and mobility of pediatric patients, particularly those with spasticity and developmental disabilities.

šŸ“š Publications

    • A Review of Current Perspectives on Motoric Insufficiency Rehabilitation following Pediatric Stroke
      Authors: Čolović, H., Zlatanović, D., Zivković, V., Jovanović, K., Nikolić, D.
      Citations: 0
      Year: 2024
    • Can pre-treatment dysfunctional voiding and incontinence scoring system score predict treatment outcome in children with dysfunctional voiding ā€“ a randomized trial
      Authors: Živković, V.D., Čolović, H., Zlatanović, D., Vlajković, M.
      Citations: 0
      Year: 2023
    • The importance of assessing general motor activity in premature infants for predicting neurological outcomes
      Authors: Zlatanović, D., Čolović, H., Živković, V., Vučić, J., ToÅ”ić, T.
      Citations: 1
      Year: 2022
    • Factors associated with poor self-reported function and quality of life in patients with end-stage knee or hip osteoarthritis immediately prior to total joint arthroplasty
      Authors: Kocić, M., Milenković, M., Nikolić, D., Čolović, H., Stojanović, Z.
      Citations: 4
      Year: 2021
    • Endometrial immunocompetent cells in proliferative and secretory phase of normal menstrual cycle
      Authors: JanoÅ”evic, D.R., JanoÅ”evic, D.R., Trandafilović, M., Dinic, S.P.-T., Dinic, S.P.-T.
      Citations: 12
      Year: 2020
    • Upper limb robotic neurorehabilitation after pediatric stroke
      Authors: Čolović, H., Dimitrijević, L., Đurić, V., Janković, S.
      Citations: 3
      Year: 2020
    • Botulinum toxin type A for spastic cerebral palsy: Is it time to change praxis?
      Authors: Čolović, H., Dimitrijevic, L., Stanković, I., Radović-JanoÅ”ević, D., Zlatanović, D.
      Citations: 1
      Year: 2020
    • The Role of Early Habilitation in Infants with Congenital Brachial Palsy
      Authors: Živković, V.D., Stanković, I., Dimitrijević, L., Spalević, M., Savić, N.
      Citations: 1
      Year: 2018
    • The effect of physical therapy in the treatment of patients with cervical dystonia with or without concomitant use of botulinum toxin
      Authors: Stanković, I., Čolović, H., Živković, V., Živković, D., Stanković, T.
      Citations: 2
      Year: 2018
    • Chemoinformatic investigation of antibiotic antagonism: The interference of thymus glabrescens essential oil components with the action of streptomycin
      Authors: Ilić, B.S., Miladinović, D.L., Kocić, B.D., Čolović, H., Nikolić, D.M.
      Citations: 3
      Year: 2017

 

ConclusionĀ 

Dr. Hristina Čolovićā€™s profile indicates strong potential for the Robotics Integration Award. Her expertise in physical medicine and rehabilitation, combined with her research into robotic neurorehabilitation, makes her an excellent candidate for recognition. With further development in broader robotics applications and enhanced collaboration with engineers, Dr. Čolović could lead the way in advancing robotic integration into rehabilitation practices, positively impacting patient care across various domains.

 

 

Ioannis Charalampopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. Ioannis Charalampopoulos
| Neuroscience | Best Researcher Award šŸ†

Professor of Pharmacology at Medical School, University of Crete,GreecešŸŽ“

Dr. Ioannis Charalampopoulos is a distinguished Professor of Pharmacology at the University of Crete’s Medical School and a Group Leader at the Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology, Hellas (FORTH). With a focus on neuropharmacology and molecular biology, his research has contributed significantly to the study of neurodegenerative diseases, brain development, and regeneration. He has an extensive academic and research career spanning over two decades, with notable achievements in the development of novel therapeutic strategies for Alzheimerā€™s and spinal cord injury.

 

Professional ProfileĀ 

Education šŸŽ“:

  • 2021-present: Director of the Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, Medical School, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden
  • 2001-2005: PhD in Pharmacology, Medical School, University of Crete
  • 1998-2000: Master of Science in Neurosciences, Medical School, University of Crete
  • 1990-1996: BSc, Department of Biology, University of Patras

Work Experience šŸ’¼:

  • 2023-present: Professor of Pharmacology, Medical School, University of Crete
  • 2018-present: Researcher/Group Leader, Institute of Molecular Biology and Biotechnology (IMBB), FORTH
  • 2021-present: Director, Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden

Skills šŸ”

Dr. Charalampopoulos is highly skilled in neuropharmacology, molecular biology techniques, and neurodegenerative disease research. His expertise includes:

  • Neurotrophin receptor structure-function analysis
  • Development of therapeutic ligands for brain regeneration
  • Neurogenesis and neuroprotection strategies
  • Animal models of Alzheimerā€™s disease and spinal cord injury
  • Human iPSC-derived neural platforms for disease modeling
  • Collaborative research in neuroscience and pharmacology

Awards and Honors šŸ†

Dr. Charalampopoulos has received multiple recognitions throughout his career, including prestigious grants for his innovative work in neuroscience and neurodegenerative disease treatment:

  • HORIZON-EIC-2022 European Commission Grant: Coordinating a project on soft-robot-assisted therapeutic delivery for neurological disorders (budget: 2.9 million euros).
  • National Flagship Project: Funding for the elucidation of the genetic basis of Alzheimer’s and Parkinson’s diseases (budget: 610,000 euros).
  • Numerous research accolades, with over 80 publications in peer-reviewed journals (h-index: 35, citations >3000).

šŸ¤ Memberships:

Dr. Charalampopoulos is a member of several prestigious scientific organizations, including:

  • International Society for Neuroscience
  • European Society of Neurochemistry
  • Society for Neuroscience (SfN)
  • Greek Society for Pharmacology

Teaching Experience šŸ‘©ā€šŸ«:

Dr. Charalampopoulos has been actively involved in educating future generations of neuroscientists, particularly through his role as the Director of the Graduate Program in Neurosciences at the University of Crete. His teaching experience includes:

  • Undergraduate and postgraduate courses in pharmacology, neuropharmacology, and molecular biology.
  • Mentoring and supervising PhD students and postdoctoral researchers in pharmacology and neuroscience.
  • Developing innovative teaching methods, including the use of human stem cell models in neuroscience research.

Research Focus šŸ”¬:

Dr. Charalampopoulos’ research interests revolve around the molecular mechanisms by which growth factors and their receptors regulate the regenerative capacity of the nervous system. Key areas include:

  • Neurotrophins: Their role in brain development, neurogenesis, neuronal survival, and repair during aging.
  • Neurodegenerative Diseases: Investigating novel therapeutic strategies for Alzheimer’s disease, Parkinsonā€™s disease, and spinal cord injury.
  • Ligand Development: Creating novel ligands targeting neurotrophin receptors to enhance regenerative and neuroprotective effects.
  • Stem Cell Models: Using human induced pluripotent stem cell-derived platforms to test therapeutics for neurodegenerative diseases.
    His ultimate goal is to decipher the signaling mechanisms underlying neurodegeneration and regeneration, leading to the development of novel drugs for brain repair.
ConclusionĀ 

Dr. Ioannis Charalampopoulos is undoubtedly a top contender for the Best Researcher Award. His exceptional contributions to neuroscience, his innovative approaches in neuropharmacology, and his ability to secure substantial research funding demonstrate that he is not only an accomplished researcher but also a transformative figure in the field of neurodegenerative diseases. His strengths lie in the originality of his work, leadership in research initiatives, and mentorship in education. With slight improvements in public outreach, collaborative networks, and clinical translation, he can further elevate his already remarkable career. Therefore, Dr. Charalampopoulos is a highly deserving nominee for the Best Researcher Award, given his outstanding scientific contributions, leadership, and lasting impact on the field of neuroscience.

šŸ“š Publilcation

  • “Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease”
    • Year: 2024
    • Journal: Frontiers in Cellular Neuroscience
    • Type: Review
    • DOI: 10.3389/fncel.2024.1422130
  • “Editorial: Steroid receptors in neuron and glia”
    • Year: 2024
    • Journal: Frontiers in Endocrinology
    • Type: Editorial
    • DOI: 10.3389/fendo.2024.1472908
  • “Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimerā€™s disease”
    • Year: 2024
    • Journal: Stem Cell Research & Therapy
    • Type: Journal Article
    • DOI: 10.1186/s13287-024-03818-w
  • “Cover Image, Volume 72, Issue 4”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24399
  • “Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer’s disease and the protective role of BDNF”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24505
  • “Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimerā€™s Disease”
    • Year: 2024
    • Type: Preprint
    • DOI: 10.21203/rs.3.rs-3886007/v1
  • “Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents”
    • Year: 2024
    • Journal: Molecules
    • Type: Journal Article
    • DOI: 10.3390/molecules29020515
  • “Butanolides and Butenolides from a Marine-Derived Streptomyces sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor”
    • Year: 2023
    • Journal: Marine Drugs
    • Type: Journal Article
    • DOI: 10.3390/md21090465
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner”
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Type: Journal Article
    • DOI: 10.3390/ijms241411683
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor Promoting Cell Death in Mouse and Human Neuronal Cells”
    • Year: 2023
    • Type: Preprint
    • DOI: 10.20944/preprints202306.1633.v1

Dr. Menghuan Wang | Cognitive Rehabilitation | Young Scientist Award

Posted on by sciencefather

Dr. Menghuan Wang | Cognitive Rehabilitation | Young Scientist Award šŸ†

Ph.D at Nanjing Normal University ,ChinašŸŽ“

šŸ‘Øā€šŸ”¬ Menghuan Wang is a dedicated PhD candidate in the field of neurorehabilitation at Nanjing Normal University, with previous academic affiliations at Nanjing Medical University. His research is centered on enhancing cognitive and motor function through non-invasive brain stimulation and innovative therapies. Wang has focused on impactful treatments for aphasia and stroke patients, as well as those undergoing maintenance hemodialysis.

 

Professional ProfileĀ 

Education šŸŽ“:

šŸŽ“ PhD Candidate, Nanjing Normal University ā€“ Specializing in neurorehabilitation, Wangā€™s academic training includes expertise in functional near-infrared spectroscopy (fNIRS) and advanced brain stimulation methods such as transcranial magnetic stimulation (TMS) and transcutaneous auricular vagus nerve stimulation (taVNS).

Work Experience šŸ’¼:

šŸ’¼ Research and Innovation ā€“ Wang has led and collaborated on significant research projects aimed at improving patient-centered neurorehabilitation, with 15 research publications in both English and Chinese journals. His work has influenced approaches to cognitive function restoration and non-invasive therapeutic techniques.

Skills šŸ”

  • Neurorehabilitation Techniques: Proficient in fNIRS, TMS, tES, and taVNS.
  • Patient-Centered Research: Developing therapies for patients with cognitive impairment and motor challenges, focusing on post-stroke recovery and cognitive decline prevention in dialysis patients.
  • Cognitive and Motor Function Restoration: Employing non-invasive brain stimulation to achieve measurable rehabilitation outcomes.

Awards and Honors šŸ†

šŸ† Award Nominee ā€“ Menghuan Wang is nominated for the Young Scientist Award and Best Researcher Award, recognizing his substantial contributions to cognitive science and neurorehabilitation. His work has garnered citations and recognition, particularly within Chinese and international scientific communities.

šŸ¤ Memberships:

šŸ¤ Professional Affiliations

  • Member, Branch of Cognitive Neurobiology, Chinese Neuroscience Society
  • Member, Chinese Association of Rehabilitation Medicine
    These memberships underscore Wangā€™s active engagement with prominent cognitive and rehabilitation networks.

Teaching Experience šŸ‘©ā€šŸ«:

Mentorship and Knowledge Sharing ā€“ As an advanced researcher, Wang frequently collaborates with peers, guiding team-based research projects and contributing to knowledge-building within his field.

Research Focus šŸ”¬:

Wangā€™s research focuses on cognitive neuroscience, neurolinguistics, and neuromodulation, with a particular emphasis on neurorehabilitation. His pioneering studies on taVNS for hemodialysis patients have shown promise in preventing cognitive impairment, offering new paths in non-invasive brain treatments.

ConclusionĀ 

Menghuan Wangā€™s research contributions make him a compelling candidate for the Young Scientist Award. His innovative use of non-invasive neuromodulation techniques in neurorehabilitation reflects both academic rigor and a commitment to patient-centered care. With a growing publication record and substantial clinical relevance, Wang shows strong potential to advance the field of cognitive neuroscience. Further expanding his collaborative and leadership roles could strengthen his profile even further, but his current accomplishments already showcase a high level of scientific achievement and innovation that aligns well with the spirit of the Young Scientist Award.

šŸ“š PublilcationĀ 

  • Transcutaneous Auricular Vagus Nerve Stimulation Combined with Task-Oriented Training to Improve Upper Extremity Function in Post-Stroke Hemiplegia
    • Year: 2024
    • Journal: Chinese Journal of Rehabilitation Medicine (Vol. 39, Issue 6, pp. 782ā€“790)
    • Authors: Wang, M., Kong, Y., Xie, M.
  • ZNF217-Activated Notch Signaling Mediates Sulforaphane-Suppressed Stem Cell Properties in Colorectal Cancer
    • Year: 2024
    • Journal: Journal of Nutritional Biochemistry (Vol. 125, Article 109551)
    • Authors: Wang, M., Tang, L., Chen, S., Li, Y., Chen, Y.
  • Transcutaneous Auricular Vagus Nerve Stimulation Improves Cognitive Decline by Alleviating Intradialytic Cerebral Hypoxia in Hemodialysis Patients: A fNIRS Pilot Study
    • Year: 2024
    • Journal: Heliyon (Article e39841)
    • Authors: Wang, M.-H., Jin, Y.-J., He, M.-F., Li, W.-W., Jiang, Z.-L.
  • Transcutaneous Auricular Vagus Nerve Stimulation with Task-Oriented Training Improves Upper Extremity Function in Patients with Subacute Stroke: A Randomized Clinical Trial
    • Year: 2024
    • Journal: Frontiers in Neuroscience (Vol. 18, Article 1346634)
    • Authors: Wang, M.-H., Wang, Y.-X., Xie, M., Lin, F., Jiang, Z.-L.
  • Diallyl Trisulfide Inhibits Gastric Cancer Stem Cell Properties Through Ī”Np63/Sonic Hedgehog Pathway
    • Year: 2023
    • Journal: Molecular Carcinogenesis (Vol. 62, Issue 11, pp. 1673ā€“1685)
    • Authors: Ge, M., Zhu, J., Yi, K., Jiang, Z., Han, H.
  • Transcranial Direct Current Stimulation Improves the Attention and Executive Function in Patients with Maintenance Hemodialysis
    • Year: 2023
    • Journal: Chinese Journal of Rehabilitation Medicine (Vol. 38, Issue 9, pp. 1221ā€“1226)
    • Authors: Chen, L., Wang, M., Li, W.
  • TEADs Serve as Potential Prognostic Biomarkers and Targets for Human Gastric Cancer
    • Year: 2022
    • Journal: BMC Gastroenterology (Vol. 22, Issue 1, Article 308)
    • Authors: Wang, M.-H., Li, B.-Z., Chen, Y., Wang, J.
  • Ī”Np63Ī± Mediates Sulforaphane-Suppressed Colorectal Cancer Stem Cell Properties Through Transcriptional Regulation of Nanog/Oct4/Sox2
    • Year: 2022
    • Journal: Journal of Nutritional Biochemistry (Vol. 107, Article 109067)
    • Authors: Chen, Y., Wang, M.-H., Wu, J.-Y., Han, H.-Y., Zhong, C.-Y.
  • TAp63Ī± Targeting of Lgr5 Mediates Colorectal Cancer Stem Cell Properties and Sulforaphane Inhibition
    • Year: 2020
    • Journal: Oncogenesis (Vol. 9, Issue 10, Article 89)
    • Authors: Chen, Y., Wang, M.-H., Zhu, J.-Y., Han, H.-Y., Zhong, C.-Y.

Prof. Dr. binli | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. Dr. binli | Neuroscience | Best Researcher Award šŸ†

Lecturer (University Professor) at yangzhou university,ChinašŸŽ“

The nominee, a PhD holder in Architecture since 2016, has demonstrated excellence in research, education, and practical applications in architecture and sustainability. His dual focus on comfort and accessibility, alongside nature-based solutions for climate resilience, addresses critical contemporary issues. His notable contributions, backed by research grants and real-world projects, underscore his commitment to advancing sustainable architecture.

 

Professional ProfileĀ 

šŸŽ“ Education

Bin Li earned his Ph.D. in Neuroscience from Nanjing Agricultural University, where his master’s thesis was recognized as an excellent thesis. His educational background laid a strong foundation for his expertise in neuroimmunology and endothelial cell research. šŸŽ“šŸ†

šŸ¢ Work Experience

As a university-appointed professor, Bin has made significant contributions to the field of Neuroscience. His work focuses on the mechanisms of mRNA methylation in endothelial cells and their role in recovery after ischemic stroke, enhancing our understanding of neurovascular repair processes. šŸ§ šŸ„

šŸ§¬ Skills

  • Bin possesses advanced research skills in molecular biology and neuroimmunology, with a strong capability in conducting complex experiments and data analysis. His ability to communicate complex scientific concepts effectively enhances his teaching and mentorship roles. šŸ§ŖšŸ“Š

Awards and Honors šŸ†

He has received numerous accolades, including the “Lv Yang Jin Feng” Outstanding Doctor award and recognition for an outstanding paper at the 19th National Academic Exchange Meeting on Neuropsychopharmacology in 2021. šŸ„‡šŸŽ–ļø

MembershipsšŸ“œĀ 

Bin is an active member of professional organizations, including the Neuroimmunology Branch of the Jiangsu Society of Immunology and the Basic Veterinary Branch of the Jiangsu Animal Husbandry and Veterinary Association, which facilitate collaboration and knowledge exchange in his field. šŸ¤šŸŒ

šŸ“š Teaching Experience

In his role as a lecturer, Bin is dedicated to educating the next generation of scientists, fostering a stimulating learning environment, and guiding students through advanced concepts in Neuroscience and immunology. šŸ“–šŸ‘Øā€šŸ«

šŸ”¬ Research Focus

His current research investigates glial cell-to-neuron and endothelial cell inter-communication during post-ischemic injury, aiming to uncover novel therapeutic strategies for brain recovery. With a total of 12 published papers and significant citations, his research is influential in the field. šŸ”šŸ§¬

ConclusionĀ 

In conclusion, Dr. Bin Li exemplifies the qualities of a leading researcher deserving of the Best Researcher Award. His innovative research, impressive publication record, and active engagement in the scientific community highlight his significant contributions to neuroscience. Addressing the areas for improvement could further amplify his impact, making him a valuable asset to both academia and society. Dr. Li’s commitment to advancing knowledge in neurovascular repair positions him as an outstanding candidate for this prestigious recognition.

šŸ“š PublilcationĀ 

  • EHR coding with hybrid attention and features propagation on disease knowledge graph
    • Year: 2024
    • Journal: Artificial Intelligence in Medicine
  • DAJLENet: A neural network based on dual attention and joint learning for explainable heart failure adverse event prediction
    • Year: 2024
    • Journal: Computers and Electrical Engineering
  • Application programming interface recommendation for smart contract using deep learning from augmented code representation
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process
  • Extraction of Corn Plant Phenotypic Parameters with Keypoint Detection and Stereo Images
    • Year: 2024
    • Journal: Agronomy
  • Ponzi Scheme Detection in Smart Contract via Transaction Semantic Representation Learning
    • Year: 2024
    • Journal: IEEE Transactions on Reliability
  • Normalization of kinship relations to enrich family network analysis: case study on China biographical database
    • Year: 2024
    • Journal: Digital Scholarship in the Humanities
  • Fine-grained smart contract vulnerability detection by heterogeneous code feature learning and automated dataset construction
    • Year: 2024
    • Journal: Journal of Systems and Software
  • Neurodynamics for Equality-Constrained Time-Variant Nonlinear Optimization Using Discretization
    • Year: 2024
    • Journal: IEEE Transactions on Industrial Informatics
  • Automatic software vulnerability classification by extracting vulnerability triggers
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process

 

 

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

MD.,PhD at Ā Medical University of Lublin , Poland

Dr. Ryszard Pluta is a distinguished neurologist and neuroscientist, with a medical degree from the Medical Academy in Lublin (1977) and a Ph.D. from the Polish Academy of Sciences (1983). He has served as a Professor at the Mossakowski Medical Research Institute and held prestigious postdoctoral fellowships at the NIH and NYS Institute for Basic Research. A recognized expert in brain ischemia and Alzheimer’s disease, Dr. Pluta has published extensively, including multiple influential books on the subject. He is a recipient of numerous awards and is an active member of several professional societies. His significant contributions to understanding the links between ischemia and Alzheimer’s have established him as a leading figure in neuropathology.

Profile:

ScopusĀ 

Education šŸŽ“

Ryszard Pluta earned his medical degree from the Medical Academy in Lublin (1971-1977) and attended Humboldt University in Berlin (1975) and the University of Cologne (1976). He completed his Ph.D. at the Polish Academy of Sciences in Warsaw (1983). He became an Associated Professor in 1992 and a full Professor in 2004 at the Mossakowski Medical Research Institute, Polish Academy of Sciences.

Work Experience šŸ’¼

Dr. Pluta has held prestigious positions, including postdoctoral fellowships at the NIH in Bethesda, USA (1986-1988), and the NYS Institute for Basic Research in New York (1988-1989). He has been a Visiting Professor at several renowned institutions, including the Max-Planck Institute for Neurological Research and Charles University in Prague.

Skills šŸ§ 

With extensive expertise in neuropathology and neurochemistry, Dr. Pluta specializes in brain ischemia and Alzheimer’s disease research. His skills encompass project management, collaboration with international research teams, and contributions to clinical studies in the field of neuroscience.

Awards and Honors šŸ†

Dr. Pluta has received numerous accolades, including recognition from the Polish Association of Neuropathologists (1980, 1986) and the Polish Academy of Sciences (1982, 1989, 1992). He was also honored by the International Brain Research Organization (1997) and the Alzheimerā€™s Association in Chicago (1998).

Membership šŸ¤

He is an active member of various professional organizations, including the Polish Association of Neuropathologists and the International Society of Neuropathology. Dr. Pluta is recognized among the World’s Top 2% scientists by Stanford University.

Teaching Experience šŸ“š

Dr. Pluta has contributed to the academic community through teaching positions at various universities, where he has shared his knowledge and expertise in neuropathology and neuroscience with students and researchers.

Research Focus šŸ”¬

His research focuses on brain ischemia, its relationship with Alzheimer’s disease, and associated neuropathological changes. He has made significant contributions, such as the documentation of identical changes in ischemic brains and those affected by Alzheimer’s, and the exploration of potential therapeutic approaches involving Ī²-amyloid peptide.

 

Publications:

  • Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer’s Disease with Survival up to 2 Years
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Trans- and Cis-Phosphorylated Tau Protein: New Pieces of the Puzzle in the Development of Neurofibrillary Tangles in Post-Ischemic Brain Neurodegeneration of the Alzheimerā€™s Disease-like Type
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • A Look at the Etiology of Alzheimer’s Disease based on the Brain Ischemia Model
    • Year: 2024
    • Journal: Current Alzheimer Research
  • Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Ischemia-Reperfusion Programming of Alzheimerā€™s Disease-Related Genesā€”A New Perspective on Brain Neurodegeneration after Cardiac Arrest
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimerā€™s Disease with 2-Year Survival
    • Year: 2023
    • Journal: Cells
  • The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimerā€™s Disease Proteinopathy
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Preservation of Biomarkers Associated with Alzheimerā€™s Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimerā€™s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
    • Year: 2023
    • Journal: Molecules
  • Post-Ischemic Permeability of the Bloodā€“Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimerā€™s Disease-Type Brain Neurodegeneration
    • Year: 2023
    • Journal: International Journal of Molecular Sciences

Dr NISHI PATEL | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr NISHI PATEL | Neuroscience | Best Researcher AwardĀ Ā  šŸ†

Research Scholar at Bhagwan Mahavir University, Surat , IndiašŸŽ“

Dr. Nishi Jayesh Patel is a dedicated research scholar at Bhagwan Mahavir University, specializing in the study of Parkinson’s Disease šŸ§ . With over four years of significant contributions in this field, she has become an expert in neurodegenerative disorders, particularly focusing on microbiology and probiotics. Dr. Patel has published research on the relationship between gut microflora and Parkinsonā€™s, exploring innovative treatments such as in-vitro probiotic formulations. She is also a member of the Parkinson’s Foundation, continually striving to advance knowledge and treatment for the disease.

 

Professional ProfileĀ 

  • Google ScholarĀ 

Education šŸŽ“

Dr. Patel holds advanced degrees in microbiology and neurological sciences, fueling her passion for neurodegenerative disease research. Her academic excellence and thorough understanding of Parkinson’s Disease enable her to make meaningful strides in the field.

Work Experience šŸ¢

Apart from her research work, Dr. Patel is a seasoned subject matter expert and has contributed significantly to academic assessment by setting papers for national and international entrance exams. Her work in this area has helped shape the academic landscape and ensure high standards for future medical professionals.

Awards and Honors šŸ†

While specific awards are not mentioned, Dr. Patelā€™sĀ numerous professional contributions, including her membership in the Parkinson’s Foundation, speak to her dedication and excellence in the field of medical research.

Research Focus šŸ”

Dr. Patelā€™s core research focuses on probiotics and their role in neurological disorders. She has identified six bacterial strains that are potential candidates for therapeutic use in Parkinsonā€™s Disease, with promising results in balancing GABA collapse, improving drug bioavailability, and controlling disease progression. These isolates show potential in controlling mood, immunity, and digestion, positively influencing patients’ well-being.

 

 

Publications :Ā 

  • Evaluating Probiotic Properties of Gut Microflora for Gut Modulation as an Adjuvant Therapy for Parkinson’s Disease
    Authors: NJ Patel, M Hajoori
    Journal: Journal of Future Foods
    Year: 2025
    Volume: 5
    Issue: 3
    Pages: 304-316
  • Isolation, Characterisation, and Screening of Gut Bacteria for Essential Probiotic Characteristics
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: European Journal of Biomedical and Pharmaceutical Sciences
    Year: 2023
    Volume: 10
    Issue: 11
    Pages: 176-179
  • Comparative Formulation and Evaluation of Probiotic Products Utilizing Different Bacterial Strains: A Comprehensive Study
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Biological Forum ā€“ An International Journal
    Year: 2023
    Volume: 15
    Issue: 5
    Pages: 1747-1752
  • Psychobiotics: The Next Generation Adjuvant Therapy and Its Revolutionary Contribution in Treatment for Parkinsonā€™s Disease
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Futuristic Trends in Medical Sciences
    Year: 2022
    Book: 21, Part 1
    Pages: 1-15
  • Bioremediation of Surfactants by Bacteria Isolated from Spume Used to Scavenge Surfactants Along with Dyes in Washing Textile Effluents
    Author: DRD Nishi Jayesh Patel
    Journal: JETIR Research Journal
    Year: 2020
    Volume: 7
    Issue: 6
    Pages: 1147-1153

 

Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Alexandros Kanellopoulos Neuroscience | Best ResearcherAwardĀ  šŸ†

Principal Scientist of Cognitive Health atĀ DSM-Firmenich, RD Innovation
SwitzerlandšŸŽ“

Alexandros Kanellopoulos is a seasoned Innovation Leader, Principal Scientist, and Clinical Director with over 20 years of expertise in Neuroscience, Metabolism, Early Life Nutrition (ELN), and Medical Nutrition. He has successfully led multidisciplinary teams, pioneered product innovations, and authored more than 20 high-impact publications. With 7 patents to his name, Alexandros excels in transforming scientific research into tangible solutions that meet market needs.

Professional ProfileĀ 

Education

Alexandros Kanellopoulos holds a Ph.D. in Neuroscience from Kapodistrian University, Greece (2008-2013), where his research focused on neurodevelopmental disorders. Prior to this, he completed his M.Sc. in Molecular Medicine (Neuroscience) at the same university (2005-2007), gaining advanced expertise in neuroscience and molecular biology. His academic foundation was established with a B.Sc. in Molecular Biology and Genetics from Dimocritus University of Thrace, Greece (2000-2005), where he developed a strong background in genetics and molecular biology.

Work Experience

In his current role as Global Principal Scientist & Clinical Director at DSM-Firmenich (2023-Present), Alexandros oversees scientific activities, driving innovation in dietary supplements and medical nutrition. Prior to this, he worked as an R&D Innovation Scientist and Project Manager at Nestle SA (2022-2023), leading the development of brain health products for Early Life Nutrition. In 2023, he also held the position of Medical, Scientific & Regulatory Affairs Manager at Nestle Nutrition, focusing on market communication and regulatory compliance. Alexandros previously served as Group Leader, Early Life Brain Metabolism at the University of Lausanne (2020-2022) and as Senior Scientist in Early Life Neuroscience (2016-2020), where he pioneered research in neurodevelopmental disorders.

SkillsĀ 

Alexandros is highly skilled in Innovation & Product Development, leading projects from concept to market. He is an expert in Clinical Research & Protocol Design, managing complex preclinical and clinical trials. His ability to lead multidisciplinary teams and drive Cross-functional Collaboration is complemented by his talent for Stakeholder Engagement & Market Alignment, ensuring alignment between research innovations and market needs. His Strategic Thinking, Problem-solving, and Emotional Intelligence are key to his success in high-impact research and business projects.

Awards & Honors

Throughout his career, Alexandros has earned more than 15 research awards, securing CHF 2.5 million in research funding. He has been awarded 7 patents as an inventor, reflecting his contributions to innovation in neuroscience and nutrition. In addition, he has delivered over 40 invited presentations at international conferences, establishing himself as a respected thought leader in his field.

Ā MembershipĀ 

Alexandros contributes to the scientific community as a Reviewer for leading neuroscience journals and serves as an Editor in scientific publications, ensuring the dissemination of high-quality research.

Teaching Experience

Alexandros is also an experienced educator, having delivered lectures in Neuroscience and Medical Sciences at the University of Lausanne and Kapodistrian University, Athens. In his academic roles, he has mentored over 20 junior scientists, fostering the next generation of researchers and innovators.

Research Focus

Alexandros’ research centers on Early Life Nutrition and its role in brain development. He is particularly focused on Neurodevelopmental Disorders such as Autism and Fragile X Syndrome. His work on Brain Energy Metabolism and Mitochondrial Function provides insights into neurotransmission and social behavior. Alexandros has also designed Preclinical and Clinical Research aimed at developing nutritional solutions to address these complex medical challenges.

Publications :Ā 

  • Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome
    šŸ§  International Journal of Molecular Sciences ā€“ 2024
    DOI: 10.3390/ijms25168787
  • Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits
    šŸ§¬ Cell ā€“ 2020
    DOI: 10.1016/j.cell.2020.02.044
  • Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
    šŸ”¬ The Journal of Neuroscience ā€“ 2020
    DOI: 10.1523/jneurosci.1846-19.2020
  • Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    šŸ§© Biological Psychiatry ā€“ 2019
    DOI: 10.1016/j.biopsych.2019.04.008
  • SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
    šŸ§  Neuron ā€“ 2019
    DOI: 10.1016/j.neuron.2019.05.002
  • Mitochondrial Dysfunction in Autism Spectrum Disorder: Clinical Features and Perspectives
    šŸ§  Current Opinion in Neurobiology ā€“ 2017
    DOI: 10.1016/j.conb.2017.05.018
  • Autism Spectrum Disorders: Translating Human Deficits into Mouse Behavior
    šŸ Neurobiology of Learning and Memory ā€“ 2015
    DOI: 10.1016/j.nlm.2015.07.013
  • Learning and Behavioral Deficits Associated with the Absence of the Fragile X Mental Retardation Protein: What a Fly and Mouse Model Can Teach Us
    šŸ§  Learning & Memory (Cold Spring Harbor, N.Y.) ā€“ 2014
    DOI: 10.1101/lm.035956.114
  • Learning and Memory Deficits Resulting from Reduction of the Fragile X Mental Retardation Protein: A Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila
    šŸ§  The Journal of Neuroscience ā€“ 2012
    DOI: 10.1523/JNEUROSCI.1347-12.2012
  • Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-blind, Placebo-controlled Study
    šŸ’Š The American Journal of Gastroenterology ā€“ 2011
    DOI: 10.1038/ajg.2011.179